JMJD3 and UTX as Key Targets for Gene-Modified Mesenchymal Stem Cell Therapy in Cartilage Tissue Engineering
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 36 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 36 samples: 36 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- JMJD3 and UTX as key targets for gene-modified mesenchymal stem cell therapy in cartilage tissue engineeringMolecular therapy : the journal of the American Society of Gene Therapy · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE303471_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1295484 and SRA study SRP603117. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 36 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9127566 Patient 1, bone marrow-derived mesenchymal stem cells, Control, H3K4me3 (ChIP)
- GSM9127567 Patient 1, bone marrow-derived mesenchymal stem cells, Control, H3K4me3 (Input)
- GSM9127568 Patient 1, bone marrow-derived mesenchymal stem cells, undifferentiated, H3K4me3 (ChIP)
- GSM9127569 Patient 1, bone marrow-derived mesenchymal stem cells, undifferentiated, H3K4me3 (Input)
- GSM9127570 Patient 1, bone marrow-derived mesenchymal stem cells, Control, H3K27me3 (ChIP)
- GSM9127571 Patient 1, bone marrow-derived mesenchymal stem cells, undifferentiated, H3K27me3 (ChIP)
- GSM9127572 Patient 1, bone marrow-derived mesenchymal stem cells, GSK-J4, H3K4me3 (ChIP)
- GSM9127573 Patient 1, bone marrow-derived mesenchymal stem cells, GSK-J4, H3K4me3 (Input)
- GSM9127574 Patient 1, bone marrow-derived mesenchymal stem cells, GSK-J4, H3K27me3 (ChIP)
- GSM9127575 Patient 1, bone marrow-derived mesenchymal stem cells, GFP, H3K4me3 (ChIP)
- GSM9127576 Patient 1, bone marrow-derived mesenchymal stem cells, GFP, H3K4me3 (Input)
- GSM9127577 Patient 1, bone marrow-derived mesenchymal stem cells, GFP, H3K27me3 (ChIP)
- GSM9127578 Patient 1, bone marrow-derived mesenchymal stem cells, JMJD3, H3K4me3 (ChIP)
- GSM9127579 Patient 1, bone marrow-derived mesenchymal stem cells, JMJD3, H3K4me3 (Input)
- GSM9127580 Patient 1, bone marrow-derived mesenchymal stem cells, JMJD3, H3K27me3 (ChIP)
- GSM9127581 Patient 1, bone marrow-derived mesenchymal stem cells, UTX, H3K4me3 (ChIP)
- GSM9127582 Patient 1, bone marrow-derived mesenchymal stem cells, UTX, H3K4me3 (Input)
- GSM9127583 Patient 1, bone marrow-derived mesenchymal stem cells, UTX, H3K27me3 (ChIP)
- GSM9127584 Patient 2, bone marrow-derived mesenchymal stem cells, Control, H3K4me3 (ChIP)
- GSM9127585 Patient 2, bone marrow-derived mesenchymal stem cells, Control, H3K4me3 (Input)
- GSM9127586 Patient 2, bone marrow-derived mesenchymal stem cells, undifferentiated, H3K4me3 (ChIP)
- GSM9127587 Patient 2, bone marrow-derived mesenchymal stem cells, undifferentiated, H3K4me3 (Input)
- GSM9127588 Patient 2, bone marrow-derived mesenchymal stem cells, Control, H3K27me3 (ChIP)
- GSM9127589 Patient 2, bone marrow-derived mesenchymal stem cells, undifferentiated, H3K27me3 (ChIP)
- GSM9127590 Patient 2, bone marrow-derived mesenchymal stem cells, GSK-J4, H3K4me3 (ChIP)
- GSM9127591 Patient 2, bone marrow-derived mesenchymal stem cells, GSK-J4, H3K4me3 (Input)
- GSM9127592 Patient 2, bone marrow-derived mesenchymal stem cells, GSK-J4, H3K27me3 (ChIP)
- GSM9127593 Patient 2, bone marrow-derived mesenchymal stem cells, GFP, H3K4me3 (ChIP)
- GSM9127594 Patient 2, bone marrow-derived mesenchymal stem cells, GFP, H3K4me3 (Input)
- GSM9127595 Patient 2, bone marrow-derived mesenchymal stem cells, GFP, H3K27me3 (ChIP)
- GSM9127596 Patient 2, bone marrow-derived mesenchymal stem cells, JMJD3, H3K4me3 (ChIP)
- GSM9127597 Patient 2, bone marrow-derived mesenchymal stem cells, JMJD3, H3K4me3 (Input)
- GSM9127598 Patient 2, bone marrow-derived mesenchymal stem cells, JMJD3, H3K27me3 (ChIP)
- GSM9127599 Patient 2, bone marrow-derived mesenchymal stem cells, UTX, H3K4me3 (ChIP)
- GSM9127600 Patient 2, bone marrow-derived mesenchymal stem cells, UTX, H3K4me3 (Input)
- GSM9127601 Patient 2, bone marrow-derived mesenchymal stem cells, UTX, H3K27me3 (ChIP)
- GSE256064 Proneural-Mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import-bulk RNAseq 56 samples shares mesenchymal, therapy
- GSE334259 A pilot study for treatment of chronic cough after COVID-19 infection by nebulization therapy of mesenchymal stem cell (MSC)-derived extracellular vesicles from 3D culture 36 samples shares mesenchymal, therapy
- GSE216842 Transcriptomic landscape of human primary stromal cells (fibroblasts, endothelial cells and mesenchymal stem cells) upon therapy-induced senescence (genotoxic chemotherapy) 24 samples shares mesenchymal, therapy
- GSE298139 Therapy-resistance in AT/RT is driven by epithelial-mesenchymal transition, extracellular matrix changes, and enrichment of CD1A+ CD207+ dendritic cells [snRNA-seq] 16 samples shares mesenchymal, therapy
- GSE231507 Impact of azide metabolic glycoengineering and bioorthogonal click chemistry cell-cell tethering in adipose tissue-derived mesenchymal stromal cells 15 samples shares mesenchymal, engineering
- GSE300789 Sustained Mesenchymal Reprogramming of Endothelial Cells after Completion of Chemotherapy [RNA-seq] 14 samples shares mesenchymal, therapy
- GSE298140 Therapy-resistance in AT/RT is driven by epithelial-mesenchymal transition, extracellular matrix changes, and enrichment of CD1A+ CD207+ dendritic cells [RNA-seq_FFPE] 12 samples shares mesenchymal, therapy
- GSE301295 Functional redundancy between UTY and UTX in regulating the localization of transcription factors involved in pluripotency [ChIP-seq_dualcross] 38 samples shares utx
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.